Gonzales AJ, Bowman JW, Fici GJ. et al.
Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy.
J Vet Pharmacol Ther 2014;
37 (04) 317-324
We do not assume any responsibility for the contents of the web pages of other providers.